News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Patented New ISO Name Approved – December 2025: Triflupyroxazin, A New N-phenylimide Herbicide From Liaoning Cynda Chemical Co., Ltd.

    Patented New ISO Name Approved – December 2025: Amfenamacril, A New Aminocyanoacrylate Fungicide From Jiangsu Pesticide Research Institute Co., Ltd.

    Delhi HC refuses FMC’s plea to stop Natco’s Cyantraniliprole commercialization

    Mirati Therapeutics Announces U.S. FDA Accelerated Approval of KRAZATI™ (adagrasib) as a Targeted Treatment Option for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

    adminDecember 16, 202202k views

    Summary :-Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted…

    Read more

    NEW ISO – DEC 2022 || HERBICIDE CORTEVA CANDIDATE PUBLISHED – INDOLAUXIPYR

    adminDecember 15, 202203.5k views

    NEW ISO – DEC 2022 – HERBICIDE CORTEVA CANDIDATE PUBLISHED – INDOLAUXIPYR Corteva also known as Dow Agrosciences LLC LLC published a…

    Read more

    Indian Farmers Fertiliser Cooperative Limited and Mitsubishi Corporation Launches Takibi (Flubendiamide 20% WG) Insecticide

    adminDecember 12, 202202.7k views

    Highlights : IFFCO and Mitsubishi Corporation formed a joint venture to produce Tabiki (Flubendiamide 20% WG). The major causes of biotic stress…

    Read more

    AstraZeneca to Acquire Neogene Therapeutics for $320 Millon.

    adminDecember 7, 202201.6k views

    AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing…

    Read more

    INDIAN PESTICIDE APPROVALS – 442ND RC MEETING – CHLORANTRANILIPROLE – FMC MOLECULE – MAJOR HIGHLIGHT

    adminDecember 6, 202202.8k views

    INDIAN PESTICIDE APPROVALS UPDATES – MINUTES OF THE 442ND REGISTRATION COMMITTEE (RC) MEETING HELD ON 18.11.2022 The 442nd meeting of the Registration…

    Read more

    FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection

    adminDecember 4, 202201.7k views

    Summary- The FDA has approved fecal microbiota, live-jslm (Rebyota; Ferring Pharmaceuticals) for the prevention of recurring Clostridioides difficile infection (CDI) among patients 18…

    Read more

    AgbioInvestor Global Ties with ChemRobotics

    adminNovember 23, 202201.8k views

    ChemRobotics   and AgbioInvestor are happy to announce the establishment of a new international partnership utilising the pharmacological intelligence platform of ChemRobotics. AgbioInvestor…

    Read more

    The FDA has Approved TZIELDTM (Teplizumab-mzwv) as the First and Only Medication Intended to Postpone the onset of Stage 3 Type 1 Diabetes (T1D) in Adult and Paediatric Patients with Stage 2 T1D Who are 8 Years of Age and Older.

    adminNovember 18, 202203k views

    Summary:- TZIELD is the first disease-modifying therapy in T1D, a life-threatening autoimmune disease In a clinical trial, in Stage 2 T1D patients,…

    Read more

    Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy Approved by the FDA as First-line Treatment for Advanced Non-small Cell Lung Cancer (NSCLC)

    adminNovember 15, 202202.1k views

    Summary: Approval based on superior survival outcomes of Libtayo plus chemotherapy, compared to chemotherapy alone, in a patient population with a wide…

    Read more

    Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for relapsed or Refractory Multiple Myeloma

    adminNovember 15, 202201.7k views

    Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) for…

    Read more

    Posts navigation

    1 … 12 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top